Clinical Trials Logo

Clinical Trial Summary

Ureteroenteric anastomotic stricture is a well-known complication of urinary diversion which occurs in 4-25% of patients. Recent study has yielded that radiation is a significant risk factor for development of ureteroenteric stricture. The goal of this study is to determine whether intraoperative use of SPY fluorescent angiography during urinary diversion reduces rate of ureteroenteric stricture. This study will include 215 patients who have undergone urinary diversion over the past 5 years as historic controls and compare ureteroenteric stricture rates to a prospective cohort of patients in whom intraoperative SPY fluorescent angiography was used at the time of urinary diversion to assess the anastomotic perfusion. This will include injection of ICG intravenously as well as utilization of the SPY device to assess ureteral perfusion before and after ureteroenteric anastomosis. Based on power analysis, this study will require approximately 50 patients in our prospective group to detect a clinically significant difference of 5% between groups. Data analysis plan includes the use of chi square test for comparison of stricture rates between groups. Clinical outcomes will be followed prospectively, with no amendment to standard follow-up per physician.


Clinical Trial Description

Ureteroenteric anastomotic stricture is a well-known complication of urinary diversion which occurs in 4-25% of patients. Strictures present clinically with flank pain, decreased renal function, pyelonephritis or may be asymptomatic and diagnosed incidentally with progressive hydronephrosis and renal impairment. Strictures are a cause of significant morbidity and health care expenditure, as treatment necessitates procedural intervention and often several inpatient admissions. Numerous studies have sought to identify risk factors for development of ureteroenteric strictures as well as opportunities for technical approaches to reduce stricture risk. Studies have demonstrated that Clavien-Dindo ≥ 3 complication and BMI were associated with higher risk of stricture. Ischemia of the anastomosis related to the tenuous ureteral blood supply is implicated in the formation of ureteroenteric stricture. Basic science and animal data have established the detrimental impact of radiation therapy on microvasculature. Radiation induced ureteral ischemia in conjunction with periureteral fibrosis make preservation of distal ureteral blood supply during urinary diversion tenuous and challenging. This is especially of concern in patients requiring pelvic exenteration for colorectal or gynecological malignancy, which often necessitate radiation therapy prior to surgical intervention. Radiation history is also an important contributor commonly in patients undergoing benign diversion for radiation cystitis. Several groups have tested whether varied surgical methods may offer risk reduction. Surgical anastomotic approach has not significantly impacted ureteroenteric stricture rate. However, a more recent study suggests that intracorporeal diversion confers a higher risk of ureteroenteric stricture. The gold standard for treatment of ureteroenteric stricture is open repair with ureteral reimplantation. Open surgical repair has success of 92-100%, while endoscopic management has success of 30-50%. A recent study demonstrated that through the use of indocyanine green (ICG) fluorescent angiography while performing urinary diversion using the DaVinci robotic system, that they were able to reduce stricture rates from 10.6% to 0%. Use of this technology allows the surgeon to evaluate the vascular supply to the ureter as well as the newly created ureteroenteric anastomosis. This significant reduction in complications has tremendous implications for improvement in patient care and reduction of morbidity. Many patients are not candidates for robotic urinary diversion and thus undergo open surgery. Fluorescent angiography has also shown promise for decreasing ureteroenteric stricture rate in open surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05022199
Study type Interventional
Source University of Virginia
Contact
Status Enrolling by invitation
Phase N/A
Start date March 1, 2021
Completion date July 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06110299 - Room Air a Safe Alternative to Dye Injection in Ureterography N/A
Completed NCT01741454 - Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction Phase 4
Completed NCT00790686 - Tolerance and Effectiveness of Ureteral Stents MEMOKATH ® 051 in Chronic Strictures of the Ureter Phase 2
Completed NCT00568724 - Urinary Biomarkers as Predictors on Renal Function in Congenital Hydronephrosis N/A
Completed NCT00250406 - Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm Formation Phase 2
Terminated NCT02419339 - Early Infancy Ureteral Reimplantation for Distal Ureteral Obstruction
Completed NCT00301470 - Functional MR Urography Phase 4
Enrolling by invitation NCT02160652 - Ureteral Reimplantation for the Treatment of Extrinsic Malignant Ureteral Obstruction N/A
Recruiting NCT01788865 - Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral Obstruction Phase 4
Completed NCT03266770 - The RELIEF™ Ureteral Stent - Assessment of Retrograde Urinary Reflux and Distal Coil Bladder Position N/A
Completed NCT02744430 - Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent Pain Phase 2
Completed NCT00169650 - Laparoscopic Pyeloplasty Registry and Database N/A
Completed NCT01542593 - Evaluating Ureteral Length Using Computed Tomography (CT) N/A
Completed NCT00166361 - Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral Stent N/A
Completed NCT00142064 - A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization Procedures Phase 2
Completed NCT04695951 - Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract Phase 2
Withdrawn NCT00199472 - Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJO N/A